In previously reported in vitro studies, we found that heme, a physiol
ogically widespread hydrophobic iron compound, can rapidly generate ox
idized low-density lipoprotein (LDL), which then becomes cytotoxic to
cultured vascular endothelial cells; both LDL oxidation and endothelia
l cytotoxicity were inhibited by incubation with exogenous alpha-tocop
herol (vitamin E) or ascorbic acid (vitamin C). Seeking relevance to i
n vivo conditions, we performed a study in which 10 human volunteers w
ere given daily antioxidant supplements of 800 IU of DL-alpha-tocopher
ol acetate alone or in combination with 1000 mg of ascorbic acid for 2
weeks. LDL resistance to heme oxidation ex vivo, as measured by the l
ag time for conjugated-diene formation, increased by as much as threef
old from a mean+/-SD of 58+/-11 to 104+/-18 minutes (P<.001); LDL alph
a-tocopherol increased from 11+/-2 to 26+/-6 molecules per LDL particl
e (P<.001); and most impressively, cytotoxicity to porcine aortic endo
thelial cells incubated with LDL conditioned with heme plus H2O2 or wi
th copper was completely prevented (cytotoxicity before supplementatio
n was 42+/-12%, decreasing after supplementation to 3+/-2%, P<.001). T
hese measurements reverted to their presupplement levels within 2 week
s after participants stopped taking antioxidant supplements and were r
eproduced in 4 subjects taking 800 IU of DL-alpha-tocopherol acetate s
upplements alone but not in the same subjects taking 1000 mg ascorbic
acid supplements alone. In conclusion, oral vitamin E supplementation
increases LDL alpha-tocopherol content, increases LDL resistance to ox
idation, and decreases the cytotoxicity of oxidized LDL to cultured va
scular endothelial cells.